On 12 October 2026, CALB (03931.HK) said it received a CSRC filing notice for full circulation of 207,102,914 domestic shares into H shares.
On 13 October 2026, TRANSSION (02636.HK) set the offer price at HKD 35.30 per H share, with H shares expected to start trading on the Main Board on 15 October.
On 12 October 2026, HAIDILAO (06862.HK) agreed to lend chairman Zhang Yong a HKD loan capped at the RMB 100 million equivalent, at HIBOR plus 60 basis points.
On 12 October 2026, SMIT (02239.HK) said Equity Transfer Agreement A completed that day and the Group no longer holds any equity interest in Xinxingji.
On 12 October 2026, SCIENTECH (02291.HK) said its MemoCarna oxide-film single-rivet PFO occluder obtained a China medical device registration certificate.
On 12 October 2026, CHINANEWTOWN (01278.HK) said its fixed-income portfolio was about RMB 3.073 billion at end-September, net of provisions for risk projects.
On 12 October 2026, LUZHU BIOTECH-B (02480.HK) said its RSV vaccine has been approved by the National Medical Products Administration for clinical trials.
On 12 October 2026, LONGFOR GROUP (00960.HK) reported nine-month contracted sales of RMB 23.14 billion for 2026, including RMB 2.30 billion in September.
On 12 October 2026, PHARMARON (03759.HK) priced a shareholder inquiry-based transfer at RMB 38.89 per share, with 13 institutions taking all 18,373,000 shares.
On 12 October 2026, LOPAL TECH (02465.HK) said its RMB 108 million structured deposit matured on 8 October 2026, recovering the principal and RMB 306,900.
On 12 October 2026, GIGADEVICE (03986.HK) said cumulative A-share buybacks reached 2.7178m shares, or 0.39% of capital, for RMB 1.03bn excluding costs.
On 12 October 2026, Q TECH (01478.HK) said September handset product sales reached 50,176 thousand units, with automotive and IoT products growing year on year.
On 12 October 2026, FUJIAN HOLDINGS (00181.HK) said Su Qingpeng is now its authorised representative under Listing Rule 3.05, effective from that date.
On 12 October 2026, SHOUGANG LANZA (02553.HK) said it signed a framework agreement with Sinopec units to promote a bioethanol-to-SAF project in Ningxia.
On October 12, 2026, Hong Kong indices diverged, with the HSI up 0.25%. YUNJI led gainers with an 18.56% rise; southbound net buying was HK$2.603 billion.
On 12 October 2026, TH MEDICAL-B (02697.HK) said its organ perfusion system supported six gene-edited pig liver experiments for up to 144 hours, a world record.
